International Society for the Study of Women's Sexual Health

ISSWSH / ISSM Joint Meeting 2019

   March 7-10, 2019    -103 days ago
   Grand Hyatt Atlanta
Atlanta, GA, USA

Program

Thursday, March 7, 2019
Morning
07:00 a.m. - 12:15 p.m.
Location: Grand Ballroom 3
Annual Pre-Course (Separate Registration Required)
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
Is subsession
Child level: 1
07:00 a.m. - 07:30 a.m.
Location: Foyer
Breakfast - Pre-Course Registrants Only
07:30 a.m. - 07:40 a.m.
Location: Grand Ballroom 3
Welcome and Introduction
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:40 a.m. - 09:15 a.m.
Location: Grand Ballroom 3
Identification of Sexual Health Problems
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
07:40 a.m. - 08:00 a.m.
Update on Epidemiology and Nomenclature
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:00 a.m. - 08:30 a.m.
Diagnosis of HSDD and Arousal Disorders
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:30 a.m. - 08:45 a.m.
Physical Exam
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
08:45 a.m. - 09:15 a.m.
Testing Procedures: Hormonal, Vascular, Neurologic
Speaker: Irwin Goldstein, MD, IF (USA)
09:15 a.m. - 09:30 a.m.
Location: Foyer
Coffee Break
09:30 a.m. - 10:15 a.m.
Location: Grand Ballroom 3
Pharmacology
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
09:30 a.m. - 09:55 a.m.
Non-Hormonal Pharmacological Treatments
Speaker: Irwin Goldstein, MD, IF (USA)
09:55 a.m. - 10:15 a.m.
Sexual Dysfunction and Other Comorbities: Treatment Considerations
Speaker: Sharon Parish, MD, IF, NCMP (USA)
10:15 a.m. - 10:55 a.m.
Location: Grand Ballroom 3
Hormones
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
10:15 a.m. - 10:40 a.m.
Hormonal Treatment: Estrogens and Progestogens
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
10:40 a.m. - 10:55 a.m.
Hormonal Treatment: Androgens
Speaker: Sharon Parish, MD, IF, NCMP (USA)
10:55 a.m. - 11:50 a.m.
Location: Grand Ballroom 3
Sexual Pain
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
10:55 a.m. - 11:15 a.m.
Painful Intercourse: Causes, Evaluation and Treatment
Speaker: Irwin Goldstein, MD, IF (USA)
11:15 a.m. - 11:35 a.m.
Vestibulodynia: Diagnosis and Treatment
Speaker: Irwin Goldstein, MD, IF (USA)
11:35 a.m. - 11:50 a.m.
Treatment Options for GSM
Speaker: Tami Rowen, MD, MS, FACOG, IF (USA)
11:50 a.m. - 12:00 p.m.
Location: Grand Ballroom 3
Q&A
Moderator: Tami Rowen, MD, MS, FACOG, IF (USA)
12:00 p.m. - 12:15 p.m.
Location: Foyer
Lunch - Pre-Course Registrants Only
Afternoon
12:15 p.m. - 12:30 p.m.
Location: Grand Ballroom 1&2
Opening Ceremony
Welcome Comments
Speakers: Annamaria Giraldi, MD, PhD, IF (Denmark) & Sharon Parish, MD, IF, NCMP (USA)
Introduction to WMSM 2020
Speaker: Yoshikazu Sato, MD, PhD (Japan)
12:30 p.m. - 01:30 p.m.
Location: Grand Ballroom 1&2
Sandra Leiblum ISSWSH Presidential Lecture
Moderators: Annamaria Giraldi, MD, PhD, IF (Denmark) & Sharon Parish, MD, IF, NCMP (USA)
How US Governmental Agencies Inadvertently Conspire Against Women's Sexual Health: A Personal Perspective
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
01:30 p.m. - 03:00 p.m.
Location: Grand Ballroom 1&2
Symposium 1: Sexually Transmitted Infections/ HPV in Men and Women
Moderator: Andrew Goldstein, MD, FACOG, IF (USA)
01:30 p.m. - 01:55 p.m.
Update on HPV Vaccines
Speaker: Richard Roden, PhD (USA)
01:55 p.m. - 02:20 p.m.
Updated HPV Screening Guidelines
Speaker: Colleen Stockdale, MD (USA)
02:20 p.m. - 02:45 p.m.
New Technologies in Cervical Cancer Screening and Treatment
Speaker: Andrew Goldstein, MD, FACOG, IF (USA)
02:45 p.m. - 03:00 p.m.
Q&A
03:00 p.m. - 03:30 p.m.
Location: Foyer
Coffee Break
03:00 p.m. - 03:30 p.m.
Location: Foyer
New Member/New Attendee Meet-Up
03:30 p.m. - 03:35 p.m.
Location: Grand Ballroom 1&2
In Memoriam - Fernand Labrie, MD, PhD (1937-2019)
03:35 p.m. - 04:15 p.m.
Location: Grand Ballroom 1&2
State of the Art Session 1: Female Genital Pain: What's He Got To Do With It?
Moderator: Sheryl Kingsberg, PhD, IF (USA)
Speaker: Marieke Dewitte, PhD (The Netherlands)
04:15 p.m. - 05:45 p.m.
Location: Grand Ballroom 1&2
Research Podium Session 1
Moderators: Joshua Gonzalez, MD (USA) & Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
04:15 p.m. - 04:25 p.m.
Pelvic Radiation Reduces Vaginal Blood Flow and Increases Vaginal Smooth Muscle Contraction (#001)
Speaker: Shelby A. Powers (USA)
04:25 p.m. - 04:35 p.m.
Men’s Sexual Bother and Wife’s Expectations for Sexual Life After Radical Prostatectomy - in Japanese Experiences (#002)
Speaker: Yoshikazu Sato, MD, PhD (Japan)
04:35 p.m. - 04:45 p.m.
Vulvar Lichen Sclerosus in Multidisciplinary Clinics: Treatment Compliance and Sexual Function (#003)
Speaker: Jaden Kohn (USA)
04:45 p.m. - 04:55 p.m.
How Science Studies Pornography Impact and What Science Can, and Cannot, Tell Us (#004)
Speaker: William Fisher (Canada)
04:55 p.m. - 05:05 p.m.
Changes in Sexuality in Ovarian Cancer Survivors and Their Partners: A Cross-sectional Study from the PROFILES Registry (#005)
Speaker: Caroline Vos (The Netherlands)
05:05 p.m. - 05:15 p.m.
A Randomized Controlled Pilot Study of Mindfulness for Sex and Intimacy in Relationships (MSIR) in the Treatment of Sexual Dysfunctions (#006)
Speaker: Julie Krieger (Denmark)
05:15 p.m. - 05:25 p.m.
A Randomized Double-Blind Placebo Controlled Trial of Autologous Platelet Rich Plasma Intradermal Injections for the Treatment of Vulvar Lichen Sclerosus (#007)
Speaker: Andrew Goldstein, MD, FACOG, IF (USA)
05:25 p.m. - 05:35 p.m.
Examining Clinician Attitudes on Sexual Health Assessment After an Educational Intervention (#008)
Speaker: Jenna Benyounes (USA)
04:15 p.m. - 05:45 p.m.
Location: Grand Ballroom 3
Instructional Course 1: Hormones for Sexual Health Concerns (Separate Registration Required)
Speakers: Alyse Kelly-Jones, MD, IF, FACOG (USA) & Rossella Nappi, MD, PhD (Italy)
Evening
05:45 p.m. - 07:15 p.m.
Location: Foyer
Welcome Reception
Friday, March 8, 2019
Morning
07:00 a.m. - 08:00 a.m.
Location: Buckhead Ballroom
Special Breakfast Symposium
08:00 a.m. - 09:00 a.m.
Location: Grand Ballroom 1&2
State of the Art Session 2: Sexuality in the Aging Couple: A New Paradigm in Assessing and Treating Sexual Dysfunction in Aging Men and Women
Moderators: Annamaria Giraldi, MD, PhD, IF (Denmark) & Eusebio Rubio-Aurioles, MD, PhD (Mexico)
08:00 a.m. - 08:15 a.m.
A Female Viewpoint
Speaker: Rossella Nappi, MD, PhD (Italy)
08:15 a.m. - 08:30 a.m.
A Male Viewpoint
Speaker: Andrea Salonia, MD (Italy)
08:30 a.m. - 08:45 a.m.
The Elderly Couple's Sexual Life: Rejuvenation or Creativity?
Speaker: Eusebio Rubio-Aurioles, MD, PhD (Mexico)
08:45 a.m. - 09:00 a.m.
Q&A
09:00 a.m. - 10:30 a.m.
Location: Grand Ballroom 1&2
Research Podium Session 2
Moderators: Heather Howard, PhD, MPH (USA) & Yoshikazu Sato, MD, PhD (Japan)
09:00 a.m. - 09:10 a.m.
Immunomodulatory Effects of Dihydrotestosterone (DHT) in Human Vaginal Smooth Muscle Cells (#009)
Speaker: Elisa Maseroli (Italy)
09:10 a.m. - 09:20 a.m.
Study on the Effect of Systemic Treatment with Testosterone on Clitoral Vascular Resistance in Basal Conditions (#010)
Speaker: Elisa Maseroli (Italy)
09:20 a.m. - 09:30 a.m.
Impact of ED, and Treatment of ED, on Female Sexual Function: Results of the Strike Up a Conversation, Females, and Partner Satisfaction Research Programs (#011)
Speaker: William Fisher (Canada)
09:30 a.m. - 09:40 a.m.
Average Time to Orgasm (TitOr) in Females During Heterosexual Penovaginal Intercourse (#012)
Speaker: Gajanan Bhat (India)
09:40 a.m. - 09:50 a.m.
Pelvic Floor Biometry Assessed Using 3D Translabial Ultrasound in Women with Vulvodynia Submitted to Physical Therapy: A Randomized Controlled Trial (#013)
Speaker: Marcela Bardin (Brazil)
09:50 a.m. - 10:00 a.m.
Examining the Role of the Physical Therapist in Treatment Response of Provoked Vestibulodynia (#014)
Speaker: Marcela Bardin (Brazil)
10:00 a.m. - 10:10 a.m.
Evidence of Low Androgenicity and Little Impact on Sexual Function or Activity with Annovera™, a Novel Contraceptive Vaginal System Releasing Segesterone Acetate and Ethinyl Estradiol (#015)
Speaker: Sharon Parish, MD, IF, NCMP (USA)
10:10 a.m. - 10:20 a.m.
Creation of a Vaginal Canal for De Novo Vaginoplasty and Salvage Vaginal Replacement For Transgender and Cisgender Women: A Proposed Novel Technique Using Right Ascending Colon (#016)
Speaker: Maurice Garcia (USA)
09:00 a.m. - 10:30 a.m.
Location: Grand Ballroom 3
Instructional Course 2: Couples Therapy (Separate Registration Required)
Speakers: Barry McCarthy, PhD (USA) & Caroline Pukall, PhD, Cpsych (Canada)
10:30 a.m. - 11:00 a.m.
Location: Foyer
Coffee Break
11:00 a.m. - 12:00 p.m.
Location: Grand Ballroom 1&2
ISSM Lecture
Moderator: Annamaria Giraldi, MD, PhD, IF (Denmark)
Updates in Sexual Medicine
Speaker: Luiz Otavio Torres, MD (Brazil)
Afternoon
12:00 p.m. - 01:00 p.m.
Location: Grand Ballroom 3
Lunch and Learn 1: Treating Couples Affected by Cancer: Mental Health Perspective
Speakers: Reanne Booker, MN, BScN, NP (Canada) & Daniela Wittmann, PhD, LMSW (USA)
12:00 p.m. - 01:00 p.m.
Location: Grand Ballroom 1&2
Lunch and Learn 2: Case Review with the Experts
Speakers: Annamaria Giraldi, MD, PhD, IF (Denmark); Tami Rowen, MD, MS, FACOG, IF (USA) & Alan Shindel, MD (USA)
01:00 p.m. - 02:00 p.m.
Location: Grand Ballroom 1&2
State of the Art Session 3: It Takes Two to Tango
Moderators: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA) & Isbelia Segnini, MA (Venezuela)
Speakers: Stanley Althof, PhD, IF (USA) & Sheryl Kingsberg, PhD, IF (USA)
02:00 p.m. - 02:30 p.m.
Location: Grand Ballroom 1&2
NAMS Lecture
Moderator: Sheryl Kingsberg, PhD, IF (USA)
Management of Genitourinary Syndrome of Menopause in Women with or at High Risk for Breast Cancer: Consensus Recommendations From NAMS and ISSWSH
Speaker: Lisa Larkin, MD, FACP, NCMP, IF (USA)
02:30 p.m. - 03:00 p.m.
Location: Grand Ballroom 1&2
The Scientific Network on Female Sexual Health and Cancer Lecture
Moderator: Sharon Parish, MD, IF, NCMP (USA)
Sexual Health in the New Era of Cancer Genetic Testing
Speaker: Sharon Bober, PhD (USA)
03:00 p.m. - 03:30 p.m.
Location: Foyer
Coffee Break
03:30 p.m. - 05:00 p.m.
Location: Grand Ballroom 1&2
Symposium 2: Pain (Female) / Vulvodynia and Vestibulodynia
Moderators: Melissa Farmer, PhD (USA) & Amy Stein, DPT, BCB-PMD (USA)
03:30 p.m. - 03:55 p.m.
Pelvic Floor Muscle Dynamics in Vestibulodynia
Speaker: Melanie Morin, PT, PhD (Canada)
03:55 p.m. - 04:20 p.m.
Novel Mechanisms in the Pathogenesis of Localized Provoked Vestibulodynia
Speaker: Megan Falsetta, PhD (USA)
04:20 p.m. - 04:45 p.m.
Brain Reorganization in Vulvodynia: Mechanisms and Treatment Implications
Speaker: Melissa Farmer, PhD (USA)
04:45 p.m. - 05:00 p.m.
Q&A
05:00 p.m. - 05:45 p.m.
Location: Grand Ballroom 1&2
Journals Session
Moderator: Luiz Otavio Torres, MD (Brazil)
05:00 p.m. - 05:20 p.m.
JSM Update
Speaker: Andrea Salonia, MD (Italy)
05:20 p.m. - 05:30 p.m.
SMR Update
Speaker: Irwin Goldstein, MD, IF (USA)
05:30 p.m. - 05:40 p.m.
SM Update
Speaker: Kwangsung Park, MD, PhD (Korea)
05:40 p.m. - 05:45 p.m.
Q&A
Evening
05:45 p.m. - 06:45 p.m.
Location: Grand Ballroom 3
ISSWSH Business Meeting (Members Only)
06:45 p.m. - 07:45 p.m.
Location: Highland Ballroom Foyer
Early Career Professionals Mixer (with drinks and food)
07:00 p.m. - 08:00 p.m.
Location: Highland Ballroom
Poster Session (with drinks and food starting at 6:45 pm at Early Career Professionals Mixer)
Penile Blood Flow Assessment Using Doppler Ultrasonography (PDUS) in Erectile Dysfunction Patients: A 10-Year Experiences at an International Hospital in Southeast Asia (#034)
Speaker: Sompol Permpongkosol (Thailand)
Variations in the Agreement between Subjective and Physiological Sexual Arousal among Women With and Without Sexual Dysfunction: The Moderating Role of Interoception (#035)
Speaker: Ariel Handy (USA)
Study on the Effect of Non-aromatizable Androgen Dihydrotestosterone (DHT) on the Sexual Behavior of Ovariectomized Female Rats Primed with Estradiol (#036)
Speaker: Elisa Maseroli (Italy)
Immunomodulatory Effects of Dihydrotestosterone (DHT) in Rat Vaginal Smooth Muscle Cells (#037)
Speaker: Elisa Maseroli (Italy)
Cervix Innervation Study: LEEP Surgery May Result in Sexual Dysfunction (#038)
Speaker: Madeline Monaghan (Canada)
Characterization of Female Periurethral Tissue: Potential Impact of Mid-urethral Sling Surgeries on Female Sexual Function (#039)
Speaker: Olivia Giovannetti (Canada)
Local Testosterone Therapy for Urethal Syndome (#040)
Speaker: Yuki Sekiguchi (Japan)
Using Antidepressants During Development is Associated with Lower Sexual Desire in Adulthood (#041)
Speaker: Tierney Lorenz (USA)
Sexual Performance Anxiety: Impact on Women and Pharmacology for Rational Nutritional Treatment (#042)
Speaker: Robert Pyke (USA)
Knowledge and Perception of Sexual Health Amongst the Saudi Population (#043)
Speaker: Hasan Alkhudairi (Saudi Arabia)
Epidemiology of HPV Risk Factors and Birth Control Methods Between HPV Positive and HPV Negative Women in Rural Arkansas (#044)
Speaker: Nina Kumar (USA)
A Closer Examination of the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer (#048)
Speaker: Lauren Walker (Canada)
Long Term Results of Peri-urethral Neurolysis for Premature Ejaculation at the Time of Inflatable Penile Prosthesis (IPP) Placement (#057)
Speaker: Joel Hillelsohn (USA)
Nurse Practitioner Practices for Discussing and Treating Genitourinary Syndrome of Menopause (#058)
Speaker: Diane Pace (USA)
What are the Associations of Body Mass Index, Sexual Dysfunction and Mood in Midlife Women? (#059)
Speaker: Stephanie Faubion (USA)
Women’s Perspectives on Aging and Menopause and Symptom Treatment (#060)
Speaker: Sheryl Kingsberg, PhD, IF (USA)
Behind Closed Doors: Assessing Sexual Medicine Health Care Professionals' Sexual Behavior and Practices (#061)
Speaker: Michael Krychman, MD, IF (USA)
The Pattern of Help-seeking Behavior Among Patients with Sexual Dysfunctions Attending in Psychiatry Outpatient Department in a Tertiary Care Hospital of Bangladesh (#062)
Speaker: Panchanan Acharjee (Bangladesh)
Effect of Type 2 Diabetes Against Sexual Function In Premenopausal Age Women in Siloam Hospital Karawaci (#063)
Speaker: Julita Nainggolan (Indonesia)
Three Cases of Persistent Genital Arousal Disorder (PGAD) (#064)
Speaker: Tomoko Saotome (Japan)
How Do Selected Factors Associated with Pregnancy and Childbirth Affect Women's Sexuality? Female Sexual Function Index Before Pregnancy and After Delivery (#065)
Speaker: Monika Zasztowt-Sternicka (Poland)
Vaginal Health for Cancer Survivors Undergoing Pelvic Radiation Therapy (#067)
Speaker: Diamond Goodwin (USA)
Female Patients with Cancer Who Endorse Sexual Problems Do Not Have Higher Suicide Ideation (#068)
Speaker: Mary Hughes (USA)
Physical Therapy and the Effects of Exercise Intervention on Common Musculoskeletal Impairments in the Postpartum Population (#069)
Speaker: Cora Huitt (USA)
Painful Sex Among White and Black Women in the United States: Results from a Nationally Representative Study (#070)
Speaker: Ashley Townes (USA)
Biopsychosocial Assessment of Persistent Genital Arousal Disorder (PGAD) in Young Girls (#071)
Speaker: Irwin Goldstein, MD, IF (USA)
Increased Central Sensitization Among Women with Painful Bladder Syndrome and Deep Dyspareunia (#072)
Speaker: Natasha Orr (Canada)
Persistent Genital Arousal Disorder Associated with Depression and Suicidality in Two Psychiatric Inpatients (#073)
Speaker: Sharon Parish, MD, IF, NCMP (USA)
Why Women Choose Vulvovaginal Plastic/Cosmetic Surgery, and What Is to Be Learned from the Literature. Personal Experience with 1000 Cases, and a Complete Review of the Literature, 2000-2018 (#074)
Speaker: Michael Goodman (USA)
Lessons from the Hottentot Venus: An Intersectional Analysis of Vulvoplasty (#075)
Speaker: Barbara Chubak (USA)
Lumping, Splitting, and Treating: Therapies are Needed for Women with Overlapping Sexual Dysfunctions (#076)
Speaker: Robert Pyke (USA)
What Factors Affect the Incidence of Female Sexual Dysfunction in Young Women? Cross-sectional Study (#077)
Speaker: Lukasz Rowicki (Poland)
Temporal Frequency-Based Typology of Female Orgasm (#079)
Speaker: Melissa Farmer, PhD (USA)
Saturday, March 9, 2019
Morning
06:00 a.m. - 08:00 a.m.
Location: Grand Ballroom 1&2
Special Interest Breakfast - PGAD
06:00 a.m. - 06:10 a.m.
Introduction/Support Group/Memorial
Speakers: Linda Cataldo (USA) & Eveline Poirer (USA)
06:10 a.m. - 06:20 a.m.
PGAD Patient Experiences
06:20 a.m. - 06:30 a.m.
Research PGAD Update
Speaker: Caroline Pukall, PhD, Cpsych (Canada)
06:30 a.m. - 06:45 a.m.
Discussion
06:45 a.m. - 06:55 a.m.
PGAD Clinical/Research Experiences
Speaker: Andrew Goldstein, MD, FACOG, IF (USA)
06:55 a.m. - 07:05 a.m.
Children/Teen PGAD Experiences
Speaker: Irwin Goldstein, MD, IF (USA)
07:05 a.m. - 07:20 a.m.
Discussion
07:20 a.m. - 07:30 a.m.
PGAD Clinical/Research Experiences
Speaker: Barry Komisaruk, PhD (USA)
07:30 a.m. - 07:40 a.m.
PGAD Clinical/Research Experiences
Speaker: Choll Kim (USA)
07:40 a.m. - 07:55 a.m.
Discussion
07:00 a.m. - 08:00 a.m.
Location: Grand Ballroom 3
Special Interest Breakfast - Scientific Network on Female Sexual Health and Cancer
Moderator: Sharon Bober, PhD (USA)
07:00 a.m. - 08:00 a.m.
Location: Buckhead Ballroom
Special Interest Breakfast - Management of Sexual Pain / Dyspareunia
Moderator: Paul Yong, MD, PhD, FRCSC (Canada)
Discussing the Upcoming SMR Review on Deep Dyspareunia Authored by Members of the SIG
Developing an Objective Tool to Measure Deep-hitting Dyspareunia
08:00 a.m. - 09:30 a.m.
Location: Grand Ballroom 1&2
Update on Clinical Guidelines
Moderator: Sharon Parish, MD, IF, NCMP (USA)
08:00 a.m. - 08:12 a.m.
HSDD Process of Care
Speaker: Anita Clayton, MD, IF (USA)
08:12 a.m. - 08:20 a.m.
The Role of Androgens in the Treatment of Genitourinary Syndrome of Menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review
Speaker: Irwin Goldstein, MD, IF (USA)
08:20 a.m. - 08:27 a.m.
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause
Speaker: Noel Kim, PhD, IF (USA)
08:27 a.m. - 08:32 a.m.
ISSWSH Nomenclature Guidelines: Update on ICD-11
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:32 a.m. - 08:35 a.m.
ISSWSH Nomenclature Guidelines: Context, Definitions
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:35 a.m. - 08:47 a.m.
ISSWSH Nomenclature Guidelines: Scientific Rationale and Supporting Evidence
Speaker: Cindy Meston, PhD (USA)
08:47 a.m. - 08:59 a.m.
The ISSWSH Process of Care for the Identification of Sexual Concerns and Problems in Women
Speaker: Sharon Parish, MD, IF, NCMP (USA)
08:59 a.m. - 09:12 a.m.
Sexual Well-being After Menopause: An International Menopause Society White Paper
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
09:12 a.m. - 09:22 a.m.
Best Practices in Medical Education in Sexual History Taking: Consensus from the Summit in Medical Education in Sexual Health
Speaker: Elizabeth Rubin, MD (USA)
09:22 a.m. - 09:30 a.m.
Q&A
09:30 a.m. - 11:00 a.m.
Location: Grand Ballroom 1&2
Symposium 3: From Brain to Bed: Sexual Desire - Drive, Motivation, Responsiveness
Moderators: Annamaria Giraldi, MD, PhD, IF (Denmark) & Sharon Parish, MD, IF, NCMP (USA)
09:30 a.m. - 10:00 a.m.
Psychological and Physiological Characteristics of Female Desire and Arousal
Speaker: Linda Vignozzi, MD (Italy)
10:00 a.m. - 10:30 a.m.
Psychological Aspects of Men and Women's Sexual Desire
Speaker: Marita McCabe, PhD, FAPS (Australia)
10:30 a.m. - 11:00 a.m.
Desire in the Couple Interaction: The Systemic Approach
Speaker: Annamaria Giraldi, MD, PhD, IF (Denmark)
11:00 a.m. - 11:30 a.m.
Location: Foyer
Coffee Break
11:30 a.m. - 12:30 p.m.
Location: Grand Ballroom 1&2
State of the Art Session 4: Sexual Consent in the Era of #MeToo
Moderators: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA) & Tami Rowen, MD, MS, FACOG, IF (USA)
Speakers: Kristen Jozkowski, PhD (USA) & Deborah Tuerkheimer (USA)
Afternoon
12:30 p.m. - 01:30 p.m.
Location: Buckhead Ballroom
Industry Sponsored Lunch Symposium
01:30 p.m. - 03:00 p.m.
Location: Grand Ballroom 1&2
Research Podium Session 3
Moderators: Noel Kim, PhD, IF (USA) & Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF (USA)
01:30 p.m. - 01:40 p.m.
Evaluation of Vulvar Health from Photographs in a Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Ospemifene in 631 Postmenopausal Women (age 40-80) with Moderate to Severe Vaginal Dryness (#017)
Speaker: Irwin Goldstein, MD, IF (USA)
01:40 p.m. - 01:50 p.m.
The Sexual Well-being of Men With and Without a History of Nonconsensual Sexual Experiences: A Preliminary Examination (#018)
Speaker: Chelsea Kilimnik (USA)
01:50 p.m. - 02:00 p.m.
Neurogenic Persistent Genital Arousal Disorder (PGAD) Secondary to Radiculopathy of Sacral Spinal Nerve Roots (SSNR): Treatment Outcome Following Spine Surgery (#019)
Speaker: Choll Kim (USA)
02:00 p.m. - 02:10 p.m.
Bioidentical Combined Estradiol and Progesterone Capsules Improved Vaginal Dryness in Women with Vasomotor Symptoms (#020)
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
02:10 p.m. - 02:20 p.m.
The Role of Office-based Somatic and Autonomic Neuro-genital Testing of Persistent Genitourinary Numbness in Women (#021)
Speaker: Irwin Goldstein, MD, IF (USA)
02:20 p.m. - 02:30 p.m.
Three Site, Prospective, Double-blind, Sham-controlled Proof-of-Principle Study of the Safety and Efficacy of CO2 Fractional Laser Therapy in Women with Vestibulodynia: An Interim Analysis (#022)
Speaker: Sue Goldstein, BA, CCRC, AASECT-CSE, IF (USA)
02:30 p.m. - 02:40 p.m.
The Language of Sexual Violence: Undergraduates' Understanding of Sexual Violence Labels and the Role of Previous Sexual Experiences (#023)
Speaker: Mackenzie Sears (USA)
02:40 p.m. - 02:50 p.m.
An Information–Motivation–Behavioral Skills Model of Sexual Consent (#024)
Speaker: Erin Shumlich (Canada)
01:30 p.m. - 03:00 p.m.
Location: Grand Ballroom 3
Instructional Course 3: Treating Sexual Side Effects from Cancer (Separate Registration Required)
Speakers: Reanne Booker, MN, BScN, NP (Canada) & Amy Stein, DPT, BCB-PMD (USA)
03:00 p.m. - 03:30 p.m.
Location: Foyer
Coffee Break
03:30 p.m. - 04:00 p.m.
Location: Grand Ballroom 1&2
SSTAR Lecture
Moderator: Sharon Parish, MD, IF, NCMP (USA)
Fertility and Sexuality
Speaker: Elizabeth Grill, Psy.D (USA)
04:00 p.m. - 05:30 p.m.
Location: Grand Ballroom 1&2
Symposium 4: Why is Testosterone so Important for the Couple?
Moderators: Andrea Salonia, MD (Italy) & Linda Vignozzi, MD (Italy)
04:00 p.m. - 04:20 p.m.
Neurobiological Role of Androgens in Desire and Orgasm in Men and Women
Speaker: James Pfaus, PhD, IF (Canada)
04:20 p.m. - 04:40 p.m.
Efficacy and Risk of Testosterone for Low Sexual Desire: Comparison of Men and Women
Speaker: Mohit Khera, MD (USA)
04:40 p.m. - 05:00 p.m.
Androgens for Women: Where Are We and How Do We Do?
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
05:00 p.m. - 05:20 p.m.
ESSM Lecture: Androgens and Cardiovascular Risks in Both Men and Women
Speaker: Giovanni Corona, MD (Italy)
05:20 p.m. - 05:30 p.m.
Q&A
05:30 p.m. - 06:00 p.m.
Location: Grand Ballroom 1&2
IUGA Lecture
Moderator: Susan Kellogg-Spadt, PhD, CRNP, IF (USA)
Life After Childbirth - Will My Life Ever Be the Same Again?
Speaker: Ranee Thakar, MD, MRCOG (United Kingdom)
Evening
06:00 p.m. - 07:30 p.m.
Location: Highland Ballroom
Poster Session (with drinks and food)
Women’s Experiences with Bremelanotide Administered, On Demand, for the Treatment of Hypoactive Sexual Desire Disorder (#080)
Presenting author: Patricia Koochaki (USA)
Lorexys Phase 2a Results: Patient’s Global Impression of Change (PGIC) (#081)
Presenting author: Robert Pyke (USA)
Nomegestrol Acetate/17beta-estradiol Does Not Negatively Alter the Vascular Resistance of Clitoral Arteries (#082)
Presenting author: Elisa Maseroli (Italy)
Proper Assessment for Cosmeto-gynecological Interventions: The Need to Evaluate the Relationship Discord, Body Dysmorphic Syndrome, and the Correct Energy-based Technology (#083)
Presenting author: Michael Krychman, MD, IF (USA)
A Review of Clinical Study Data on Ristela(TM), a Supplement Blend for Improved Sexual Function in Women (#084)
Presenting author: Sharon Parish, MD, IF, NCMP (USA)
Exploring Comorbidity of Anxiety and Depression in Vulvodynia with Associated Overactive Pelvic Floor Muscle Dysfunction (#085)
Presenting author: Vaishnavi Govind (USA)
Describing the Clinical Approach to Diagnosis and Treatment of Patients With Hypoactive Sexual Desire Disorder (#086)
Presenting author: Sharon Parish, MD, IF, NCMP (USA)
Contraception Among Young Women – Assessment of Current Trends, Level of Patients’ Satisfaction and Quality of Contraceptive Counseling (#087)
Presenting author: Magdalena Zgliczyńska (Poland)
Validation of the Vulvovaginal Symptoms Questionnaire in Women with Vulvar Dermatoses to Assess Sexual Function & Quality of Life (#088)
Presenting author: Jaden Kohn (USA)
Exploring Comorbidity of Anxiety and Depression in Lichen Sclerosus (#089)
Presenting author: Vaishnavi Govind (USA)
Effects of Bipolar Radiofrequency Treatment on Subjective and Objective Endpoints in Post-Partum Pelvic Floor Disorders (#090)
Presenting author: Jennifer Berman (USA)
An Initial Study on the Effect of Functional Electrical Stimulation in Erectile Dysfunction: A Randomized Controlled Trial (#091)
Presenting author: Cristiane Carboni (Brasil)
Phase III Study Evaluating Efficacy and Safety of Ospemifene in Menopausal Women with Moderate to Severe Vaginal Dryness: Overall Patient Satisfaction with Treatment (#094)
Presenting author: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy (#095)
Presenting author: Michael Krychman, MD, IF (USA)
Effect of CO2 Fractional Laser on Female Lower Urinary Tract Symptoms by Genitourinary Syndrome of Menopause (#096)
Presenting author: Noriko Ninomiya (Japan)
A Socio-cultural Model for Ending FGM/C at Community and Health Facility Levels (#097)
Presenting author: Joachim Osur (Kenya)
Persistent Genital Arousal Disorder: A Public Health Concern with Low Awareness (#098)
Presenting author: Carrie Aisen (USA)
Flibanserin vs. Mini-dose Trazodone for Female Sexual Dysfunction? A Challenge (#099)
Presenting author: Robert Pyke (USA)
Rationale and Design for a Phase II Trial of Abobotulinumtoxina (Dysport) in the Management of Vulvodynia (#100)
Presenting author: Andrew Goldstein, MD, FACOG, IF (USA)
Increasing Public Search Interest in Vaginal Laser Therapy: Changes Over Time and Geography (#101)
Presenting author: Carrie Aisen (USA)
The Impact of the Timing of Alcohol Consumption on the Safety and Tolerability of Flibanserin (#102)
Presenting author: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
The Effect of Evening Alcohol Consumption and Bedtime Administration of Flibanserin on the Safety of Flibanserin (#103)
Presenting author: Sheryl Kingsberg, PhD, IF (USA)
Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder (#104)
Presenting author: Robert Pyke (USA)
Spironolactone May Be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder (#105)
Presenting author: Leia Mitchell (USA)
Online Pelvic Floor Physical Therapy Group Program for Women with Persistent Genital Arousal Disorder: A Descriptive Feasibility Study (#106)
Presenting author: Robyn Jackowich (Canada)
Perceptions of Sexual Desire and Sexual Arousal: Do They Make a Difference Among Females? (#107)
Presenting author: Eusebio Rubio-Aurioles, MD, PhD (Mexico)
Interpersonal Violence Exposure as a Predictor of Early Romantic and Sexual Experiences (#108)
Presenting author: Davia Steinberg (USA)
Domains of Sexual Disgust (#109)
Presenting author: Courtney Crosby (USA)
Validation of a Short-form Version of the YSEX Instrument (#110)
Presenting author: Bridget Freihart (USA)
The Attractiveness of Risky Behaviors: A Preliminary Analysis of Evolutionary Implications for Sexual Risk-taking (#111)
Presenting author: Courtney Crosby (USA)
Infidelity Behavior in Longterm Relationships - Men and Women. A Qualitative, Phenomenological Interview Study (#112)
Presenting author: Ditte Skakke (Denmark)
"Did you come?" Culturally Grounded Psychological Treatment for Female Orgasmic Disorder (#113)
Presenting author: Erica Marchand (USA)
I Do....Not! Consummating the Unconsummated Marriage (#114)
Presenting author: Phillis Mims-Gillum (USA)
Exploring Pain-related Anxiety in Pudendal Neuralgia (#115)
Presenting author: Vaishnavi Govind (USA)
Blood Flow of Dorsal Clitoral Artery Assessed with Color Doppler Ultrasound in Women with Vulvodynia Compared to Healthy Controls (#116)
Presenting author: Etienne Cordeiro (Brazil)
Listening to Women with Endometriosis-associated Sexual Pain: Interim Findings from EndoViews (#117)
Presenting author: Paul Yong, MD, PhD, FRCSC (Canada)
Use of Intravaginal Diazepam in Treatment of Pelvic Tension Myalgia: A Case Series (#118)
Presenting author: Shaleeza Kaderali (Canada)
The Vulvodynia Experience Questionnaire (VEQ): Qualitative Development of a New Patient-reported Outcome Measure for Vulvodynia (#119)
Presenting author: Andrew Goldstein, MD, FACOG, IF (USA)
Bipolar Radiofrequency Treatment of Labia Majora and Menora: A Minimally Invasive Solution to a Growing Surgical Problem (#120)
Presenting author: Jennifer Berman (USA)
Single-center Experience with Vestibulectomy for the Treatment of Vestibulodynia and Dyspareunia (#121)
Presenting author: Rachel Rubin (USA)
Sex Hormone Fluctuations and Their Effects on Sexual Function of IUS Users (#123)
Presenting author: Kaley Ferguson (USA)
Running Out of Desire? Examining the Relationship Between Exercise and Sexual Function (#124)
Presenting author: Brooke Bouza (USA)
Linear Shockwave Tissue Coverage (LTSC) in the Treatment of Erectile Dysfunction (ED) (#125)
Presenting author: Kelly Lurz (USA)
The Role of a Multimodal Analgesic Protocol in Decreasing Use of Narcotics (#126)
Presenting author: Christopher Graziano (USA)
Sunday, March 10, 2019
Morning
07:00 a.m. - 08:00 a.m.
Location: Buckhead Ballroom
Mentor Breakfast
08:00 a.m. - 09:30 a.m.
Location: Grand Ballroom 1&2
Research Podium Session 4
Moderators: Brooke Faught, DNP, WHNP-BC, NCMP, IF (USA) & Kwangsung Park, MD, PhD (Korea)
08:00 a.m. - 08:10 a.m.
Direct Determination of Kinetic and Equilibrium Binding of Flibanserin to 5HT1A and 5HT2A Receptors (#025)
Speaker: Noel Kim, PhD, IF (USA)
08:10 a.m. - 08:20 a.m.
Female Orgasm and Overall Sexual Function in a Sample of 303 US Women - A Descriptive Study (#026)
Speaker: Ditte Skakke (Denmark)
08:20 a.m. - 08:30 a.m.
Preliminary Evidence for a Relationship Between Physiological Synchrony and Sexual Satisfaction (#027)
Speaker: Bridget Freihart (USA)
08:30 a.m. - 08:40 a.m.
What is the Relation Between Depressive Disorders, Dyspareunia and Other Sexual Dysfunctions? (#028)
Speaker: Lukasz Rowicki (Poland)
08:40 a.m. - 08:50 a.m.
Bremelanotide for Hypoactive Sexual Desire Disorders in the RECONNECT Studies: Analysis of Baseline Free Testosterone Level Quartile Subgroups (#029)
Speaker: Anita Clayton, MD, IF (USA)
08:50 a.m. - 09:00 a.m.
Improving Practitioner Knowledge and Clinical Competence in Managing Menopause-associated Dyspareunia and Female Sexual Dysfunction through Educational Interventions: Interim Analysis (#030)
Speaker: Jim Metropoulos (USA)
09:00 a.m. - 09:10 a.m.
Modified-approach for "Mini Male Urethral Sling" Placement with Inflatable Penile Prosthesis for Erectile Dysfunction and Climacturia or Mild Stress Urinary Incontinence: A Two-center Experience (#031)
Speaker: Joel Hillelsohn (USA)
09:10 a.m. - 09:20 a.m.
Proposal and Initial Validation of the Sexual Distress Scale - Short Form in Male and Female Samples (#032)
Speaker: Pablo Santos-Iglesias (Canada)
09:20 a.m. - 09:30 a.m.
Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-blind, Single Dose, Seven-way Crossover Study (#033)
Speaker: James Simon, MD, CCD, NCMP, FACOG, IF (USA)
08:00 a.m. - 09:30 a.m.
Location: Grand Ballroom 3
Instructional Course 4: Energy Based Treatments (Separate Registration Required)
Speakers: James Simon, MD, CCD, NCMP, FACOG, IF (USA) & Lauren Streicher, MD (USA)

Save The Date

ISSWSH Fall Course 2019
  November 14-16, 2019    149 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ - USA

ISSWSH Annual Meeting 2020
  March 5-8, 2020    261 days left
  Renaissance Orlando at Seaworld, Orlando, FL, USA

Latest Tweets

Transgender health - hormone management after 50 https://t.co/fKLiIGEndP ISSWSH
Direct correlation between Sexual Dysfunction and low Dyadic adjustment for women with Urinary Incontinence… https://t.co/NEueFLRGsm ISSWSH
Half of #HIV patients are women. Then why are most HIV research subjects men? https://t.co/wJYEpfpdoC ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!